1. Methyl retinoate has been converted into methyl 5,6-monoepoxyretinoate by reaction with monoperphthalic acid. The epoxy acid ester on alkaline hydrolysis gave 5,6-monoepoxyretinoic acid. 2. Treatment of the 5,6-monoepoxy compounds with ethanolic hydrochloric acid gave the corresponding 5,8-epoxy (furanoid) compounds. 3. With lithium aluminium hydride, the acid and the ester groups were selectively reduced to primary alcohols. 4. Administration of methyl 5,6-monoepoxyretinoate intraperitoneally and subcutaneously had good growth response in vitamin A-deficient rats. 5. 5,6-Monoepoxyretinoic acid, when given intraperitoneally as the sodium salt, was 157 % as active as all-tran8-retinyl acetate. 6. Methyl 5,6-monoepoxyretinoate was hydrolysed to the epoxy acid by rat-liver homogenate. It had 35% of the biological activity of all-trans-retinyl acetate in the rat when given orally.
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Several attempts have been made to modify the vitamin A molecule to discover the essential structural requirements of the molecule to fulfil its multifarious functions. The high biological activities of the side-chain-oxidized derivative of vitamin A, i.e. retinoic acid (Van Dorp & Arens, 1946; Malathi, Subba Rao, Seshadri Sastry & Ganguly, 1963) , as well as the ,B-ionine-ring-oxidized derivative, i.e. 5,6-monoepoxyvitamin A , suggest that 5,6-monoepoxyretinoic acid, which is oxidized both at the side-chain and at the ,B-ionine ring, may well be biologically more potent than retinoic acid or 5,6-monoepoxyvitamin A. There have been several claims of isolation of metabolites of retinoic acid that are biologically more potent than retinoic acid after giving the latter to vitamin A-deficient rats (Wolf, Bergan & Sundaresan, 1963; Yagishita, Sundaresan & Wolf, 1964; Dunagin, Zachman & Olson, 1964; Zile & DeLuca, 1965) . None of these compounds has yet been fully characterized or obtained in sufficient amounts to test conclusively for their high biological activity.
The present paper describes the preparation, properties, metabolism and biological potency of 5,6-monoepoxyretinoic acid. EXPERIMENTAL Synthetic retinoic acid (Hoffmann-La Roche, Basle, Switzerland) was used for the preparation of methyl retinoate. All other reagents and chemicals were as described by . All melting points are corrected.
Spectroscopic measurements. The ultraviolet-and visibleabsorption spectra of compounds were measured with a Beckmann spectrophotometer (model DU). Infrared spectra of substances were taken on a Perkin-Elmer (model 137) Infracord spectrometer as Nujol mull.
Preparation of methyl retinoate. Methyl retinoate was prepared from retinoic acid (1-0g.) by using dimethyl sulphate and NaOH (Heilbron, Jones & Wright, 1936 (Bohme, 1955) Reduction of methyl 5,6-monoepoxyretinoate by lithium aluminium hydride. Methyl 5,6-monoepoxyretinoate (20mg.) was treated with 60mg. of LiAlH4 in 40ml. of dry peroxidefree diethyl ether. The reaction was over in 35min. and the reaction product was 5,6-monoepoxyretinol H, 9.5. C21H3003 requires: C, 76-4; H, 9.1%).
The compound was reduced by LiAlH4 to 5,8-monoepoxyretinol in 20min. C20H2gO3 requires: C, 76-0; H, 8-9%).
Chromatographic behaviour. The Rp values of these compounds on thin-layer chromatography (John, Lakshmanan, Jungalwala & Cama, 1965) and reverse-phase chromatography (Jungalwala & Cama, 1962) Metabolic experiments. For oral administration, methyl 5,6-monoepoxyretinoate and retinyl acetate were prepared in refined deodorized groundnut oil containing 0-5% of atocopherol (concentrations 0-5 and 1 0 ug./0-05ml. ofdiluent oil). They were administered to animals with an Agla micrometer syringe (Burroughs Wellcome, Beckenham, Kent). 5,6-Monoepoxyretinoic acid was dissolved in ethanol and neutralized with dilute NaOH. oa-Tocopherol was added and, after removing light petroleum, the solution was suitably diluted with 0-1 M-Na2HPO4 solution, adjusted to pH 10-5 to give the required concentration.
For intraperitoneal administration, the standard and test substances were dissolved in ethanol. 5,6-Monoepoxyretinoic acid was prepared as in oral feeding, but the dilution was made with 0-1M-Na2HPO4 solution containing the required amount of Tween 20. oc-Tocopherol and Tween 20 were added to the retinyl acetate solution in ethanol, and, after removal of the light petroleum, the solution was suitably diluted with 0-1m-Na2HPO4 solution. The final dispersions contained 0-05mg. of a-tocopherol, 0-3mg. of Tween 20 and 0-5, 1-0 and 2-0/Ag. of the standard and test substances in 0-1ml. of the solution. The solutions were freshly prepared every 3 days.
Male albino rats of this Institute strain maintained on normal stock colony diet were used, when they reached the plateau stage of vitamin A deficiency . The biological assays were carried out essentially as described by Bliss & Gyorgy (1951) acccording to USP XIV (1950) specifications.
RESULTS
The structures of the parent 5,6-and 5,8-monoepoxyvitamin A compounds have been described previously The ultraviolet-absorption spectra of 5,6-monoepoxyretinoic acid in different solvents are shown in Fig. 1 .
In the infrared spectra, the shoulder at 3145 cm.-1 present in those of the 5,6-monoepoxy compounds was absent from those of the 5,8-monoepoxy compounds and also the parent compounds. A peak at 1718 cm.-1 was present in the ester compounds, and is due to the ester carbonyl group. The free acid compounds showed a broad peak at about 2632 cm.-dueto '-OH' ofthe carboxylgroup. The other characteristics were similar to those already reported Biological potency of methyl 5,6-monoepoxyretinoate. The growth rate (g./week) over 4 weeks of individual litter-mate rats receiving methyl 5,6-monoepoxyretinoate and retinyl acetate orally was measured. All the negative controls lost considerable weight and died before the end of the assay. The mean weekly gain in weight (4.0 and 6.1g. for methyl 5,6-monoepoxyretinoate and 9 6 and 13 0g. for all-trans-retinyl acetate for the daily dosages of 0.5 and lO,ug. of the compounds respectively) plotted against the logarithm of dose gave lines parallel to each other for the standard and test doses. The biological potency of methyl 5,6-monoepoxyretinoate administered orally, as compared with that of retinyl acetate, was found to be 35% (in molar terms).
Biological potency of 5,6-monoepoxyretinoic acid. 5,6-Monoepoxyretinoic acid was administered orally as the sodium salt at dosages of 0 5 and 1O,ug., the same standard doses being kept for all-tran8-retinyl acetate. Each dosage was given to eight vitamin A-deficient rats. All the rats receiving 5,6-monoepoxyretinoic acid decreased in weight and some of them died by the third week ofthe experiment, while the rats receiving the standard compound gained weight as usual.
Surprisingly, when 5,6-monoepoxyretinoic acid was given intraperitoneally at dosages of 0*5, 1.0 and 2.0,ug. to vitamin A-deficient rats, the same doses being kept for all-tran8-retinyl acetate under the same conditions, each dose being given to eight rats, the animals receiving 5,6-monoepoxyretinoic acid showed considerable increase in weight compared with the standards. All the negative controls lost considerable weight and most of them died before the end of the bioassay. The mean weekly gain in weight plotted against the logarithm of the dose gave lines for the standard and test doses that were parallel to each other (Fig. 2) . The biopotency of 5,6-monoepoxyretinoic acid as compared with that of all-tran8-retinyl acetate was 157%. Growth of rats naintained on methyl 5,8-monoepoxyretinoate. Methyl 5,8-monoepoxyretinoate (1 ,g./rat/day) was administered orally to eight vitamin A-deficient rats for 4 weeks. The average weight gain (g./week) was 2g., which was one-third that of rats receiving a similar dose of methyl 5,6-monoepoxyretinoate. Methyl 5,8-monoepoxyretinoate has much less biological activity than the corresponding 5,6-monoepoxy compound.
On administering 5,6-monoepoxyretinoic acid or methyl 5,6-monoepoxyretinoate intraperitoneally or subcutaneously at a single dose of 4.0,ug./rat/day to vitamin A-deficient rats, their eye lesions were cured. But rats subsisting on 5,6-monoepoxyretinoic acid as the sole vitamin A substitute eventually showed signs of blindness in 2 months, as judged by their physical behaviour. This may be because 5,6-monoepoxyretinoic acid is not reduced in vivo to the alcohol or the aldehyde form to take part in vision (Lakshmanan & Cama, 1966) . However, this aspect could not be unequivocally proved since facilities for taking an electroretinogram of 5,6-monoepoxyretinoic acid-fed rats were not available. DISCUSSION The expoxidation of methyl retinoate results in the hypsochromic shift of the absorption maximum by 15m,u (Table 1) , which is similar to that found for retinyl acetate . Retinoic acid itself, on reaction with monoperphthalic acid, gives rise to the corresponding 5,6-monoepoxide, but, owing to the strong adsorption characteristics of these free acid compounds, they could not be separated on an alumina coluimn. By contrast, methyl retinoate could be easily separated from methyl 5,6-monoepoxyretinoate by chromatography on a column of deactivated alumina and the free epoxy acid could be obtained from the epoxy acid ester on hydrolysis.
There are different reports about the biological activity of retinoic acid, depending on the mode of assay (Arens & Van Dorp, 1946; Van Dorp & Arens, 1946; Boguth, Horn, Soliman & Weiser, 1960; Murray, 1962; Malathi et al. 1963; De Man, Van Leeuwen & Roborgh, 1964; Baxter, 1963) . The biopotency of retinoic acid in various assays has been reviewed by Ames (1965) . Baxter (1963) failed to demonstrate a high degree of biological activity for retionic acid when administered orally. He attributed the lack of activity to the probable destruction of the compound on storage. In our assays, 5,6-monoepoxyretinoic acid also failed to promote growth of vitamin A-deficient rats by oral administration, even though the compound was freshly prepared every 3 days. The freshly prepared compound, however, when administered by the intraperitoneal route, showed profound biological activity. This clearly shows that the inability of the compound to exert its biological activity, when administered orally, is not due to its destruction on storage, but may well be due to its destruction during passage through the stomach or due to its rapid excretion from the body.
It is noteworthy that 5,6-monoepoxyretinoic acid is 157% as active as all-tran8-retinyl acetate when administered intraperitoneally. This is the first time such a high biological activity has been reported for any of the metabolic congeners of vitamin A (cf. Ames, 1965) . However, as explained by Thompson (1965) for retinoic acid, the enhanced activity of 5,6-monoepoxyretinoic acid was deduced when the growth response of rats for 5,6-monoepoxyretinoic acid given intraperitoneally was compared with the growth response for retinyl acetate by a similar route. It is apparent that the growth response of retinyl acetate by the intraperitoneal route is comparatively poorer than by the oral route. Nevertheless, when the growth response of 5,6-monoepoxyretinoic acid by the intraperitoneal route is compared with similar response of retinyl acetate by the oral route, a biological activity approximately the same (108%) as that of 5,6-monoepoxyretinoic acid is obtained. Consequently, 5,6-monoepoxyretinoic acid, which is in a more oxidized state than retinoic acid as well as 5,6-monoepoxyretinal, has profound biological activity when administered intraperitoneally and it may well be that it is far ahead of any of these vitamin A derivatives in the proposed scheme of active metabolism of vitamin A (Dowling & Wald, 1960) . Wolf et al. (1963) , after giving retinoic acid to vitamin A-deficient rats, obtained an acidic fraction containing an 'active vitamin A compound' from the intestinal lipid extract. This fraction had an absorption spectrum with inflexions at 310-315 and 335m,u. This may very well be compatible with the fractions containing 5,6-monoepoxyretinoic acid.
